Essai squalamine

An evaluation of the tolerance and efficacy of Squalamine in the treatment of scalp ringworm or Tinea capitis in school aged children in Mali

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201306000522355

Enrollment

Registered

2013-03-15

Start date

2011-05-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and Connective Tissue Diseases Paediatrics Dermatophytosis

Interventions

Topical squalamine

Placebo

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Children aged between 6 and 15 years Sexe male Attending the primary school of Sirakoro-Meguetana Willingness to have hair shaved prior to treatment Confirmed clinical and mycological diagnosis of tinea capitis Consent provided by parents

Exclusion criteria

Exclusion criteria: Children with dermatophyte infection of the skin Children who received a conventional or traditional (oral or topical) antifungal treatment within one month before the study Children with any grave medical condition that could interfere with compliance to study procedures

Design outcomes

Primary

Measure	Time frame
Mycological and clinical cure of tinea capitis lesions	—

Secondary

Measure	Time frame
Occurence of local and systemic adverse events;Mycological cure ;Partical clinical response (aspect, size of tinea capitis lesions, hair growth score	—

Countries

Mali

Contacts

Public ContactOgobara Doumbo

Head of Department, Director of MRTC

okd@icermali.org+223 66753396

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026